Rainbow Hospice Corp 2139 Tapo St Ste 213, Simi Valley, CA, 93063 | |
(805) 562-0269 |
News Archive
A team comprised of scientists at VIB, KU Leuven and UZ Leuven has made significant progress in uncovering the connection between psychological factors and the immune system. Their findings are based on an investigation of a massive drinking water contamination incident in Belgium in 2010, and are now published in the leading international medical journal Gut.
An Australian-owned obesity drug, developed by Melbourne-based biotechnology company Metabolic Pharmaceuticals Limited, is set to enter final human trials next year after successfully completing a Phase 2b human trial which proved that the drug induces weight loss and is very well tolerated with no evidence of the side effects commonly experienced with existing obesity drugs.
The warning came as the Chief Medical Officer, Sir Liam Donaldson, published a new landmark report on physical activity and health - At Least Five A Week. Smoking and unhealthy diet have long been established as major causal factors for chronic disease but the report says that inactive living is equally important.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.
› Verified 8 days ago
Name | Rainbow Hospice Corp |
---|---|
Location | 2139 Tapo St Ste 213, Simi Valley, California |
Hospice ID | 551533 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
SSA county code | 660 |
News Archive
A team comprised of scientists at VIB, KU Leuven and UZ Leuven has made significant progress in uncovering the connection between psychological factors and the immune system. Their findings are based on an investigation of a massive drinking water contamination incident in Belgium in 2010, and are now published in the leading international medical journal Gut.
An Australian-owned obesity drug, developed by Melbourne-based biotechnology company Metabolic Pharmaceuticals Limited, is set to enter final human trials next year after successfully completing a Phase 2b human trial which proved that the drug induces weight loss and is very well tolerated with no evidence of the side effects commonly experienced with existing obesity drugs.
The warning came as the Chief Medical Officer, Sir Liam Donaldson, published a new landmark report on physical activity and health - At Least Five A Week. Smoking and unhealthy diet have long been established as major causal factors for chronic disease but the report says that inactive living is equally important.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.
› Verified 8 days ago
NPI Number | 1801060793 |
Organization Name | Rainbow Hospice Corp. |
Address | 2139 Tapo St Simi Valley, California, 93063 |
Phone Number | (805)526-0269 |
News Archive
A team comprised of scientists at VIB, KU Leuven and UZ Leuven has made significant progress in uncovering the connection between psychological factors and the immune system. Their findings are based on an investigation of a massive drinking water contamination incident in Belgium in 2010, and are now published in the leading international medical journal Gut.
An Australian-owned obesity drug, developed by Melbourne-based biotechnology company Metabolic Pharmaceuticals Limited, is set to enter final human trials next year after successfully completing a Phase 2b human trial which proved that the drug induces weight loss and is very well tolerated with no evidence of the side effects commonly experienced with existing obesity drugs.
The warning came as the Chief Medical Officer, Sir Liam Donaldson, published a new landmark report on physical activity and health - At Least Five A Week. Smoking and unhealthy diet have long been established as major causal factors for chronic disease but the report says that inactive living is equally important.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.
› Verified 8 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
A team comprised of scientists at VIB, KU Leuven and UZ Leuven has made significant progress in uncovering the connection between psychological factors and the immune system. Their findings are based on an investigation of a massive drinking water contamination incident in Belgium in 2010, and are now published in the leading international medical journal Gut.
An Australian-owned obesity drug, developed by Melbourne-based biotechnology company Metabolic Pharmaceuticals Limited, is set to enter final human trials next year after successfully completing a Phase 2b human trial which proved that the drug induces weight loss and is very well tolerated with no evidence of the side effects commonly experienced with existing obesity drugs.
The warning came as the Chief Medical Officer, Sir Liam Donaldson, published a new landmark report on physical activity and health - At Least Five A Week. Smoking and unhealthy diet have long been established as major causal factors for chronic disease but the report says that inactive living is equally important.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.
› Verified 8 days ago
Home Health Aides | 1 |
Counselors | 3 |
Homemakers | 1 |
Licensed Practical or Vocational Nurses | 1 |
Medical Social Workers | 1 |
Physicians | 1 |
Registered Nurses | 2 |
Other Personnel | 1 |
Total Employees | 11 |
---|
News Archive
A team comprised of scientists at VIB, KU Leuven and UZ Leuven has made significant progress in uncovering the connection between psychological factors and the immune system. Their findings are based on an investigation of a massive drinking water contamination incident in Belgium in 2010, and are now published in the leading international medical journal Gut.
An Australian-owned obesity drug, developed by Melbourne-based biotechnology company Metabolic Pharmaceuticals Limited, is set to enter final human trials next year after successfully completing a Phase 2b human trial which proved that the drug induces weight loss and is very well tolerated with no evidence of the side effects commonly experienced with existing obesity drugs.
The warning came as the Chief Medical Officer, Sir Liam Donaldson, published a new landmark report on physical activity and health - At Least Five A Week. Smoking and unhealthy diet have long been established as major causal factors for chronic disease but the report says that inactive living is equally important.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.
› Verified 8 days ago
Home Health Aides | 1 |
Others | 3 |
Total Volunteers | 4 |
---|
News Archive
A team comprised of scientists at VIB, KU Leuven and UZ Leuven has made significant progress in uncovering the connection between psychological factors and the immune system. Their findings are based on an investigation of a massive drinking water contamination incident in Belgium in 2010, and are now published in the leading international medical journal Gut.
An Australian-owned obesity drug, developed by Melbourne-based biotechnology company Metabolic Pharmaceuticals Limited, is set to enter final human trials next year after successfully completing a Phase 2b human trial which proved that the drug induces weight loss and is very well tolerated with no evidence of the side effects commonly experienced with existing obesity drugs.
The warning came as the Chief Medical Officer, Sir Liam Donaldson, published a new landmark report on physical activity and health - At Least Five A Week. Smoking and unhealthy diet have long been established as major causal factors for chronic disease but the report says that inactive living is equally important.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.
› Verified 8 days ago
Hospice Care Of The Valley Inc Location: 1176 Roadrunner Way, Simi Valley, California, 93065 Phone: (805) 562-0269 |
A & C Health Care Unlimited Llc Location: 1687 Erringer Road, Suite #211, Simi Valley, California, 93065 Phone: (805) 562-0269 |
Hospice Of St Mary Location: 1985 Yosemite Ave Suite #240, Simi Valley, California, 93063 Phone: (805) 562-0269 |
Valley Hospice Services Llc Location: 3355 Cochran Street, Suite #203, Simi Valley, California, 93063 Phone: (805) 562-0269 |